On Thursday, February 6, 2025, Peabody (NYSE: BTU) will announce results for the quarter and year ended December 31, 2024. A conference call with management is scheduled for 10 a.m. CT on Thursday, February 6, 2025. Instructions for the conference call participation and accessing a replay, as well as other investor data, will be available […]
(NASDAQ:JFBR),(NASDAQ:JFBRW), Tel Aviv, Israel, Jan. 28, 2025 (GLOBE NEWSWIRE) — Jeffs' Brands Ltd (“Jeffs' Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, announced today that its wholly-owned (100%) subsidiary, Fort Products Limited. (“Fort”) has signed an agreement with a developer, to integrate the DeepSeek platform, an artificial
New U.S. equity and incomequantitative products backed by Fidelity's Quantitative Research and Investment Team leveraging decades of research Fidelity Investments Canada ULC (Fidelity) today launched three new products built on Fidelity's robust quantitative and fundamental research. New quantitative funds — Fidelity Absolute Income Fund – including ETF Series (FCAB/FCAB.U) — Fidelity Advanced U.S. Equity Fund
Pearl Diver Credit Company Inc. (NYSE: PDCC) (the “Company”) today announced financial results for the fourth quarter ended December 31, 2024. https://mma.prnewswire.com/media/2548649/PDCC_Logo.jpg Fourth Quarter 2024 Results — Net asset value per share of common stock $19.89 as of December 31, 2024. — NII for the quarter ended December 31, 2024 was $3.4 million, or $0.50
Greenway Greenhouse Cannabis Corporation (CSE: GWAY) (OTCQB:GWAYF) (“Greenway”orthe”Company”),acultivatorofhigh-quality greenhouse cannabis for the Canadian market, is pleased to announce that two new MillRite SKUs will be available for purchase in Ontario in the coming weeks. https://mma.prnewswire.com/media/2607381/Greenway_Greenhouse_Cannabis_Corporation_Greenway_Expands_Ontari.jpg Greenway is expanding its MillRite Lavender Haze product line with a new 10×0.35g pre-roll SKU. After the success of our
— Obesity programs: — Phase 2 BMT-801 clinical study with MC4Ragonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide — Topline results expected 1Q calendar year 2025 — General obesity, weight loss management, and rareneuroendocrine and genetic diseases, including hypothalamic obesity — Multiple clinical trials targeted to commence 2H calendar year 2025 withlong-acting MC4R peptide and/or MC4R
Conference Call Scheduled for Wednesday, February 12, 2025 at 11:00 a.m. Eastern Time W. P. Carey Inc. (W. P. Carey, NYSE: WPC), a leading net lease REIT, announced today that it will release its financial results for the fourth quarter and full year ended December 31, 2024 after the market closes on Tuesday, February 11,
Fiera Comox Partners Inc. (“Fiera Comox”), an affiliate of Fiera Capital Corporation (TSX: FSZ), is pleased to announce its acquisition of 6,650 acres of private timberlands in the United States. Situated in temperate coastal Oregon, the estate is located in one of the most attractive and globally competitive softwood producing regions in the world and
— Centers for Disease Control and Prevention (the “CDC”) reported 105,007 drug overdose deaths – with 90% involving syntheticopioids like fentanyl — Mazindol ER potentially offers a non-opioid alternative, addressing the underlying neurochemical imbalances associated with fentanyl addiction. — Mazindol ER is patent protected beyond September 2038 NLS Pharmaceutics Ltd.(NASDAQ: NLSP) (NASDAQ: NLSPW) (“NLS” or
NextEra Energy, Inc. (NYSE: NEE) today is reaffirming its long-term financial expectations following today's business update by XPLR Infrastructure, LP (NYSE: NEP). As discussed on its fourth-quarter and full-year 2024 financial results call held on Jan. 24, 2025, NextEra Energy continues to expect adjusted earnings per share to be in the ranges of $3.45 to